Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2024-03-11 00:00:00 ET · period of report 2024-03-07 · accession 0000950170-24-029529 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-11 | 2024-03-07+ | SRPT | Estepan Ian Michael | CFO | F - Tax | $122.25 | -1,561 | 36.2K | -4% | -$190.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-07 | F | D | 526 | $120.49 | 37,199 | D | — | — | (F1) Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023. |
| 2 | Common | Common Stock | 2024-03-08 | F | D | 1,035 | $123.14 | 36,164 | D | — | — | (F2) Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022. |